home


CATALOG PRODUCTS ARCHIVES FEEDBACK SEARCH
  alphbetical index Catalog Number index MSDS index Deprotection Volumes 1-5 User guide to Purification Literature Highlights Listing of oligo houses FAQ  

Catalog Number: 10-1936-xx

Description: Thiol-Modifier C6 S-S

1-O-Dimethoxytrityl-hexyl-disulfide,1'-[(2-cyanoethyl)-(N,N-diisopropyl)]-
phosphoramidite
Formula: C42H61N2O5S2PM.W.: 769.05F.W.: Reduced FW - 196.2 Unreduced FW - 328.4

Diluent: Anhydrous Acetonitrile
Add fresh diluent to product vial to recommended concentration and swirl vial occasionally over several minutes until product is completely dissolved. (Some oils may require between 5 and 10 minutes.) Use care to maintain anhydrous conditions. In case of transfer to alternate vial type, ensure recipient vial has been pre-dried. For more information, see http://www.glenres.com/Technical/TB_ABITransfer.pdf.
Coupling: Standard coupling time. Use 0.02 M Iodine for Oxidation.
Deprotection: After normal deprotection, the disulfide can be cleaved at room temperature in 30 minutes with 100 mM DTT pH 8.3 - 8.5 in the buffer of your choice. Technical Bulletin
Storage: Freezer storage, -10 to -30°C, dry
Stability in Solution: 2-3 days
Catalog InformationMaterial Safety Data Sheet

Frequently Asked Technical Question

QUESTION: Do you have a biotin phosphoramidite containing a disulfide linker which can be cleaved later with DTT to release the DNA from a streptavidin support?

RESPONSE:No. However, this can be produced on the synthesizer by adding to the 5'- terminus first 5'-thiol-modifier C6 S-S (10-1936) followed by BioTEG phosphoramidite (10-1955). This should generate a biotinylated primer with a long spacer arm containing the disulfide linkage which can be cleaved later with DTT.


QUESTION: What is the best method to make peptide-oligonucleotide conjugates?

RESPONSE:It would seem that the best method to make peptide-oligo conjugates would be to use Fmoc chemistry and synthesize the peptide off an oligo synthesized on amino-CPG. However, deprotection of peptides synthesized using Fmoc chemistry requires 50% TFA and t-boc synthesized peptides require HF both of which would severely damage if not completely hydrolyze the oligo.

The best and most straight foward method is to use a heterobifunctional crosslinking reagent to link a synthetic peptide, containing an N-terminal lysine, to a 5'-Thiol modified oligo or conversely a 5'-amino modified oligo to a cysteine containing peptide . A good crosslinking reagent is N-Maleimido-6-aminocaproyl- (2'-nitro,4'-sulfonic acid)-phenyl ester . Na + (mal-sac-HNSA) from Bachem Bioscience (cat. # Q-1615). Reaction of this crosslinker with an amino group releases the dianion phenolate, 1-hydroxy-2-nitro -4-benzene sulfonic acid a yellow chromophore. The chromophore allows both quantitation of the coupling reaction as well as act as an aid in monitoring the seperation of "activated peptide" from free crosslinking reagent using gel filtration.

Method A: Couple Peptide Amine To Oligo Thiol (Note peptide MW must be > 5,000 to be excluded from desalting column). This method best for oligo-enzyme conjugation.

Step 1: Synthesize a peptide with an N-terminal, or internal, lysine (The epsilon amino group is more reactive than an alpha amino group).

Step 2: Synthesize an oligonucleotide with a 5' Thiol group.

Step 3: React peptide with excess mal-sac-HNSA (pH 7.5 Sodium phosphate)

Step 4: Seperation of peptide-mal-sac conjugate from free crosslinker and buffer exchange (pH 6.0 Sodium phosphate) using a gel filtration column (NAP or eq.). Note peptide must be large enough to seperate from the free linker which can be visualized as a yellow band. Do not collect yellow band with peptide.

Step 5: Activate thiol modified oligo, desalt and buffer exchange (pH 6 Sodium phosphate) on NAP 5 column.

Step 6: React acitvated peptide with Thiol modified oligo.

Step 7: Purify Peptide-Oligo conjugate by ion exchange chromatography on Nucleogen DEAE-500-10 or eq. Elution order: free peptide, peptide-oligo, free oligo.

Method B: Couple Oligo Amine To Peptide Cysteine (Note oligos > 15mers are excluded from desalting column). Use above procedure switching oligo for peptide.

Step 1: Synthesize a peptide with an N-terminal, or internal, cysteine

Step 2: Synthesize an oligonucleotide with a 5' amino modifier.

Step 3: Purify oligo Trityl-on by RP HPLC or cartridge.

Step 4: React oligo with excess mal-sac-HNSA (pH 7.5 Sodium phosphate)

Step 5: Seperation of oligo-mal-sac conjugate from free crosslinker and buffer exchange (pH 6 Sodium phosphate) using a gel filtration column (NAP or eq.). Note oligo must be large enough to seperate from the free linker which can be visualized as a yellow band. Do not collect yellow band with oligo.

Step 6: Dissolve peptide in pH 6.0 Sodium phosphate buffer and react with activated oligo.

Step 7: Purify Peptide-Oligo conjugate by ion exchange chromatography on Nucleogen DEAE-500-10 or eq. Elution order: free peptide, peptide-oligo, free oligo.


DILUTION/COUPLING DATA

The table below shows pack size data and, for solutions, dilutions and approximate couplings based on normal priming procedures. Please link for more detailed usage information with the various synthesizers.

ABI 392/394
Cat.No.Pack
Size
Grams/
Pack
0.1M Dil.
(mL)
LV40LV20040nm0.2µm1µm10µm
Approximate Number of Additions
10-1936-020.25grams.25grams3.25955735.6325.91194.75
10-1936-90100µmoles.077grams120127.55.4541
Expedite
Cat.No.Pack
Size
Grams/
Pack
Dilution
(mL)
Molarity50nm0.2µm1µm15µm
Approximate Number of Additions
10-1936-020.25grams.25grams4.85.0790.656.6341.185.66
10-1936-90100µmoles.077grams1.5.0723.614.7510.731.48
Beckman
Cat.No.Pack
Size
Grams/
Pack
Dilution
(mL)
Molarity30nm200nm1000nm
Approximate Number of Additions
10-1936-020.25grams.25grams4.85.0792.257.6341.91
10-1936-90100µmoles.077grams1.5.0725.215.7511.45

11/04/2011 | http://www.glenres.com/ProductFiles/10-1936.html